Drug Search Results
More Filters [+]

Octinoxate

Alternative Names: octinoxate, shade uvaguard
Latest Update: 2020-04-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: UV Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Canada | India | Sri Lanka | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Octinoxate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title